Petra M. Nederlof - Concepedia

Author

Petra M. Nederlof

Also Known As

Nederlof, Petra, Nederlof, Petra M., P M Nederlof, P Nederlof, P. M. Nederlof, P. Nederlof, P.M. Nederlof, Petra M Nederlof, Petra M. Nederlof, Petra Nederlof

256

Publications

9.5K

Citations

H-Index

113

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute Amsterdam UMC Location University of Amsterdam University Medical Center Groningen Delft University of Technology

About

Petra M. Nederlof is an author at The Netherlands Cancer Institute specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	31	4.1K
2	Engineering	7	7	1.2K
3	Health Sciences	2	2	288
4	Natural Sciences	2	2	131
5	Management	1	1	10

Petra M. Nederlof

Publications

9.2K

Citations

H-Index

Page 1

	Year	Citations
AACR Project GENIE: Powering Precision Medicine through an International Consortium Fabrice André, Mónica Arnedos, Alexander S. Baras, Cancer Discovery	2017	1.9K
BRCA1 tumour suppression occurs via heterochromatin-mediated silencing Quan Zhu, Gerald M. Pao, Alexis Huynh, Nature Tumor BiologyChromatinMedicineTumor SuppressorCancer Genetics	2011	481
Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancers Jacqueline J.L. Jacobs, Petra Keblusek, Els C. Robanus-Maandag, Nature Genetics Breast OncologyMedicinePathologyBreast CancerCancer Biology	2000	368
Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Frans B.L. Hogervorst, Petra M. Nederlof, Cathal J. McElgunn, PubMed EngineeringGeneticsPathologyGene CharacterizationMolecular Genetics	2003	316
Multiple fluorescence in situ hybridization Petra M. Nederlof, S. van der Flier, J. Wiegant, Cytometry EngineeringCytogeneticsDna AnalysisMolecular BiologyCancer Detection	1990	267
Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. Lodewyk F.A. Wessels, Tibor van Welsem, Augustinus A. M. Hart, PubMed Brca1 MutationBreast OncologyGeneticsComparative Genomic HybridizationPathology	2002	253
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs Daphne van der Velden, Louisa R. Hoes, Hanneke van der Wijngaart, Nature Drug RepositioningOncologyPreclinical Drug EvaluationDrug RepurposingPharmacology	2019	252
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers Esther H. Lips, Lennart Mulder, Anne M.M. Oonk, British Journal of Cancer	2013	238
Three‐color fluorescence in situ hybridization for the simultaneous detection of multiple nucleic acid sequences Petra M. Nederlof, Ramadan A. Abuknesha, J. Wiegant, Cytometry	1989	220
A multiplex PCR predictor for aCGH success of FFPE samples Eric H van Beers, Simon A. Joosse, M J Ligtenberg, British Journal of Cancer Pathology ArchivesEngineeringDna AnalysisPathologyGenomics	2005	220

Page 1